Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gyrus ACMI is a global leader in the design and manufacture of minimally invasive surgical (MIS) devices, focusing on the clinical specialties of urology, gynecology, and otolaryngology. The company is best known for its proprietary PlasmaKinetic (PK) technology, an advanced bipolar electrosurgery platform that enhances surgical precision and patient safety. Since its acquisition by Olympus Corporation in 2008, Gyrus ACMI has been integrated into Olympus's Medical Systems Division, significantly expanding its reach in the surgical energy market. Their portfolio includes a wide range of endoscopes, forceps, and visualization systems used in procedures such as transurethral resection of the prostate and laparoscopic hysterectomies. The company continues to drive innovation in energy-based therapies to improve clinical outcomes and reduce recovery times.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gyrus ACMI.